Holdings of Health Care Fund
Rydex Series Funds ·132 declared positions · as of Mar 31, 2026
Original filing · Net assets 19.2M $ · Ten largest lines: 24.2 % of the equity sleeve
Sector breakdown
- Health care 65.9 %
- Materials 1.1 %
- Technology 0.7 %
- Consumer discretionary 0.6 %
- Industrials 0.5 %
- Unattributed 31.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 90.2 %
- IE 2.6 %
- GB 1.6 %
- DK 1.6 %
- CH 1.3 %
- NL 0.9 %
- IL 0.8 %
- DE 0.6 %
- BM 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 119 | 16.4M $ | 90.18 % |
| 2 | IE | 3 | 466.2K $ | 2.57 % |
| 3 | GB | 2 | 295.8K $ | 1.63 % |
| 4 | DK | 2 | 284K $ | 1.56 % |
| 5 | CH | 2 | 231K $ | 1.27 % |
| 6 | NL | 1 | 158.5K $ | 0.87 % |
| 7 | IL | 1 | 141.3K $ | 0.78 % |
| 8 | DE | 1 | 114.6K $ | 0.63 % |
| 9 | BM | 1 | 93.8K $ | 0.52 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 767 | 705.5K $ | 3.67 % |
| 2 | Johnson & Johnson | 2,562 | 626.3K $ | 3.25 % |
| 3 | AbbVie Inc | 2,273 | 494.4K $ | 2.57 % |
| 4 | Merck & Co Inc | 3,751 | 451.2K $ | 2.34 % |
| 5 | UnitedHealth Group Inc | 1,485 | 401.8K $ | 2.09 % |
| 6 | Thermo Fisher Scientific Inc | 732 | 359.8K $ | 1.87 % |
| 7 | Amgen Inc | 995 | 350.1K $ | 1.82 % |
| 8 | Abbott Laboratories | 3,259 | 334.6K $ | 1.74 % |
| 9 | Pfizer Inc | 11,904 | 334.3K $ | 1.74 % |
| 10 | Gilead Sciences Inc | 2,379 | 331.6K $ | 1.72 % |
| 11 | Intuitive Surgical Inc | 704 | 324.5K $ | 1.69 % |
| 12 | Danaher Corp | 1,546 | 293.1K $ | 1.52 % |
| 13 | Bristol-Myers Squibb Co | 4,808 | 291.6K $ | 1.52 % |
| 14 | Stryker Corp | 838 | 275.4K $ | 1.43 % |
| 15 | Vertex Pharmaceuticals Inc | 599 | 267.5K $ | 1.39 % |
| 16 | McKesson Corp | 289 | 250.1K $ | 1.30 % |
| 17 | Cencora Inc | 791 | 248.5K $ | 1.29 % |
| 18 | Regeneron Pharmaceuticals, Inc. | 309 | 238.7K $ | 1.24 % |
| 19 | Boston Scientific Corp | 3,803 | 238.6K $ | 1.24 % |
| 20 | CVS Health Corp | 3,288 | 236.1K $ | 1.23 % |
| 21 | Cigna Group/The | 798 | 212.9K $ | 1.11 % |
| 22 | Elevance Health Inc | 712 | 208.4K $ | 1.08 % |
| 23 | HCA Healthcare Inc | 436 | 206.3K $ | 1.07 % |
| 24 | Zoetis Inc | 1,509 | 178.4K $ | 0.93 % |
| 25 | Cardinal Health, Inc. | 833 | 176K $ | 0.91 % |
| 26 | Alnylam Pharmaceuticals Inc | 526 | 174K $ | 0.90 % |
| 27 | IDEXX Laboratories Inc | 309 | 173.6K $ | 0.90 % |
| 28 | Medtronic PLC | 1,996 | 173K $ | 0.90 % |
| 29 | Becton Dickinson & Co | 1,095 | 172.2K $ | 0.89 % |
| 30 | Edwards Lifesciences Corp | 2,128 | 170.4K $ | 0.89 % |
| 31 | Insmed Inc | 1,004 | 164.2K $ | 0.85 % |
| 32 | Novo Nordisk A/S | 4,453 | 163.6K $ | 0.85 % |
| 33 | ICON PLC | 1,465 | 162.1K $ | 0.84 % |
| 34 | AstraZeneca PLC | 805 | 158.8K $ | 0.82 % |
| 35 | Argenx SE | 217 | 158.5K $ | 0.82 % |
| 36 | Alkermes PLC | 4,404 | 155.7K $ | 0.81 % |
| 37 | BEONE MEDICINES LTD | 515 | 152.9K $ | 0.79 % |
| 38 | Agilent Technologies Inc | 1,311 | 149.4K $ | 0.78 % |
| 39 | Jazz Pharmaceuticals PLC | 785 | 148.4K $ | 0.77 % |
| 40 | GE HealthCare Technologies Inc | 2,066 | 147.1K $ | 0.76 % |
| 41 | ResMed Inc | 652 | 146.4K $ | 0.76 % |
| 42 | Waters Corp | 489 | 145.6K $ | 0.76 % |
| 43 | IQVIA Holdings Inc | 842 | 143.6K $ | 0.75 % |
| 44 | Teva Pharmaceutical Industries Ltd | 4,690 | 141.3K $ | 0.73 % |
| 45 | Natera Inc | 699 | 139.8K $ | 0.73 % |
| 46 | United Therapeutics Corp | 234 | 138.8K $ | 0.72 % |
| 47 | Mettler-Toledo International Inc | 110 | 138.7K $ | 0.72 % |
| 48 | GSK PLC | 2,483 | 137K $ | 0.71 % |
| 49 | Biogen Inc | 734 | 134.6K $ | 0.70 % |
| 50 | Royalty Pharma PLC | 2,759 | 132.3K $ | 0.69 % |
| 51 | Veeva Systems Inc | 752 | 132.1K $ | 0.69 % |
| 52 | Dexcom Inc | 1,981 | 124.4K $ | 0.65 % |
| 53 | STERIS PLC | 562 | 124.3K $ | 0.65 % |
| 54 | Novartis AG | 807 | 123.3K $ | 0.64 % |
| 55 | Labcorp Holdings Inc | 460 | 122.7K $ | 0.64 % |
| 56 | Humana Inc | 706 | 122.4K $ | 0.64 % |
| 57 | Ascendis Pharma A/S | 526 | 120.3K $ | 0.63 % |
| 58 | CRISPR Therapeutics AG | 2,510 | 119.4K $ | 0.62 % |
| 59 | Quest Diagnostics Inc | 597 | 117K $ | 0.61 % |
| 60 | Illumina Inc | 944 | 116.4K $ | 0.60 % |
| 61 | West Pharmaceutical Services Inc | 458 | 114.8K $ | 0.60 % |
| 62 | BioNTech SE | 1,289 | 114.6K $ | 0.60 % |
| 63 | Revolution Medicines Inc | 1,163 | 113.1K $ | 0.59 % |
| 64 | Alcon AG | 1,481 | 111.6K $ | 0.58 % |
| 65 | Moderna Inc | 2,169 | 110.2K $ | 0.57 % |
| 66 | Zimmer Biomet Holdings Inc | 1,185 | 107.1K $ | 0.56 % |
| 67 | Hologic Inc | 1,389 | 105K $ | 0.55 % |
| 68 | Incyte Corp | 1,105 | 104K $ | 0.54 % |
| 69 | Centene Corp | 3,106 | 101.7K $ | 0.53 % |
| 70 | Viatris Inc | 7,429 | 100.4K $ | 0.52 % |
| 71 | Bridgebio Pharma Inc | 1,325 | 98.4K $ | 0.51 % |
| 72 | Cooper Cos Inc/The | 1,355 | 96.9K $ | 0.50 % |
| 73 | Tenet Healthcare Corp | 511 | 96.4K $ | 0.50 % |
| 74 | Neurocrine Biosciences Inc | 719 | 94.7K $ | 0.49 % |
| 75 | Guardant Health Inc | 1,020 | 94.2K $ | 0.49 % |
| 76 | Roivant Sciences Ltd | 3,385 | 93.8K $ | 0.49 % |
| 77 | Insulet Corp | 445 | 93.4K $ | 0.49 % |
| 78 | Ionis Pharmaceuticals Inc | 1,231 | 92.4K $ | 0.48 % |
| 79 | Elanco Animal Health Inc | 3,838 | 91.8K $ | 0.48 % |
| 80 | Medpace Holdings Inc | 191 | 91.7K $ | 0.48 % |
| 81 | Align Technology Inc | 533 | 91.4K $ | 0.47 % |
| 82 | Exelixis Inc | 2,010 | 86.2K $ | 0.45 % |
| 83 | Revvity Inc | 957 | 83.8K $ | 0.44 % |
| 84 | BioMarin Pharmaceutical Inc | 1,472 | 83.2K $ | 0.43 % |
| 85 | Charles River Laboratories International Inc | 482 | 83.1K $ | 0.43 % |
| 86 | Ensign Group Inc/The | 412 | 83K $ | 0.43 % |
| 87 | Apellis Pharmaceuticals Inc | 2,036 | 81.9K $ | 0.43 % |
| 88 | Arrowhead Pharmaceuticals Inc | 1,305 | 81.8K $ | 0.43 % |
| 89 | Universal Health Services Inc | 441 | 78.9K $ | 0.41 % |
| 90 | Cytokinetics Inc | 1,193 | 78.6K $ | 0.41 % |
| 91 | Vaxcyte Inc | 1,305 | 75.8K $ | 0.39 % |
| 92 | Bio-Techne Corp | 1,443 | 75.4K $ | 0.39 % |
| 93 | Axsome Therapeutics Inc | 434 | 73.4K $ | 0.38 % |
| 94 | Masimo Corp | 410 | 72.9K $ | 0.38 % |
| 95 | Baxter International Inc | 4,330 | 72.7K $ | 0.38 % |
| 96 | Halozyme Therapeutics Inc | 1,125 | 72.7K $ | 0.38 % |
| 97 | HealthEquity Inc | 856 | 71.5K $ | 0.37 % |
| 98 | Madrigal Pharmaceuticals Inc | 134 | 70.1K $ | 0.36 % |
| 99 | Henry Schein Inc | 933 | 68.8K $ | 0.36 % |
| 100 | Protagonist Therapeutics Inc | 643 | 67.8K $ | 0.35 % |